Miscellaneous Quiz / Anti-psychotics

Random Miscellaneous Quiz

Can you name the Anti-psychotics?

 Plays Quiz not verified by Sporcle

Forced Order
Score 0/59 Timer 20:00
Use: 'Schizophrenia'
SE: ANS: Loss of accom, dry mouth, diff urinating, constipation (from muscarinic cholinoceptor block); orthostatic hypotension, impotence, failure to ejaculate, (from α adrenocept
Ziprasidone class
Quetiapine class
Thioridazine class
Use: Schizophrenia and manic phase of bipolar disorder
P-kinetics: Less efficacious mood stabilizer
Use: bipolar if Li+ is ineffective. Can also be used in combo with Li+
Clozapine class
Lamotrigine class
Thiothixene class
P-kinetics: D4 = α1 > 5-HT2 > D2 = D1 ** also potent at H1 -> sedation. Agranulocytosis in 2% of pts -- mand. weekly blood cts. Be careful & slow withdrawing -- cholinergic reboun
MOA: Na+/Li+ exchanger in AP. Enhances actions of serotonin, decreases NE & DA turnover, may block DA receptor sensitivity, may augment synthesis of ACh
P-kinetics: Monovalent cation, well absorbed (complete in 6-8 hrs, peak levels in 30 min - 2 hrs). Distributed in TBW, some sequestered in bone, no PRO binding.
SE: Few EPS but notable weight gain
P-kinetics: α1 = 5-HT2 >D2 >D1. Inexpensive, lots of side effects. Be careful and slow withdrawing -- cholinergic rebound.
P-kinetics: Notable SE include cardiotoxicity & retinal pigmentation. Be careful & slow withdrawing -- cholinergic rebound.
Valproic acid class
Trifluoperazine class
Use: acute mania or prophylactic. Can be used as monotherapy or in combo for refractory pts
Molindone class
SE: Skin discoloration (blue-gray), rash
SE: Renal: polydipsia, polyuria. Cardiac: 'sick sinus' brady-tachy. Pregnancy: renal clearance increases during pregnancy and decreases postpartum (watch for toxicity);
P-kinetics: Efficacy = lithium during early weeks of therapy
Use: bipolar depression
SE: Rare toxicities: neuroleptic malignant syndrome (life threatening!!) --- caused by excessive rapid blockade of dopamine receptors (extremely sensitive extrapyramidal effects);
SE: Muscle rigidity, impaired sweating, fever, autonomic instability (BP & HR) - tx w/ muscle relaxants (diazepam, dantrolene), dopamine agonist (bromocriptine), cooling (if fever)
SE: Broad efficacy, few EPS at low dose, EPS and hypotension at high dose. Dosing daily or Q 2 weeks
SE: Endocrine system: amenorrhea-galactorrhea, infertility, impotence (from dopamine receptor blockade resulting in hyperprolactinemia).
P-kinetics: Most are readily but incompletely absorbed. Most are highly lipid soluble & PRO bound (92-99%), large vol of distrib, much longer DOA than predicted by t1/2.
SE: Teratogenic -- contraindicated during pregnancy
SE: Tardive dyskinesia: late-occuring, choreoathetoid-like mvmts, caused mainly by older antipsychotics, continue even when drug is d/c'd, may be irreversible.
Lithium carbonate class
MOA: Block a variety of CNS, ANS, & endocrine effects via blockade of a variety of receptors: dopamine, α1 adrenergic, muscarinic ACh, H-1, & 5-HT2 receptors
Perphenazine class
P-kinetics: Extensive first pass metabolism (except thioridazine). Very little is excreted unchanged. Elimination half-lives vary from 10-24 hours.
Use: May help tx-resistant patients. Avoid for first episodes (compliance!!)
Risperidone class
Pimozide class
Chlorpromazine class
Anti-manic and mood stablizer
P-kinetics: Not metabolized, 90% excreted in urine. T1/2 = 20 hours
P-kinetics: Systemic availability from 25-35%. Major metabolite is mesoridazine, which is more potent than the parent compound. Fatal if OD --> ventricular arrythmias.
SE: Other: weight gain (from possibly combined H1 and 5-HT2 blockade). Dysmorphogenesis: relatively safe during pregnancy, however, there is a small increase in teratogenic risk.
Carbamazepine class
Haloperidol class
SE: Uncertain toxicities
Aripiprazole class
Use to prevent recurrence in bipolar disorder
SE: GI: n/v, diarrhea. Neuro: motor movement disorders (tremor - reduced by propanolol and atenolol), mental confusion (toxic doses). Thyroid: hypothyroid like symptoms.
Fluphenzine class
P-kinetics: D2 > D1 = D4 > α1 > 5-HT2. 65% bioavailability. Severe EPS.
Use: Good for negative & positive symptoms (schizophrenia, acute mania, and bipolar). Avoid for first episodes (compliance!!)
MOA: Note: 5-HT2A receptor activation on dopaminergic cell bodies and axon terminals inhibits the release of dopamine… thus 5-HT2A antagonists --> more release of dopamine
Loxapine class
MOA: 5-HT2A & D2 agonists. Lower D2 potency -> fewer EPS.
SE: CNS: Parkinson's syndrome, akathisia, dystonia (from dopamine receptor blockade); tardive dyskinesia (supersensitivity of dopamine receptors), toxic-confusional state (from mus
SE: enters breastmilk at 30-50% of plasma levels (poor suck reflex, cyanosis, hepatomegaly); dysmorphogenesis unclear -- may cause cardiac malformations. Other: edema, leukocytosis
Olanzapine class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Join for Free
Log In

You Might Also Like...

Show Comments


Created Oct 9, 2011ReportFavoriteNominate

Top Quizzes Today

Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.

Report this User

Report this user for behavior that violates our Community Guidelines.